Candace Brown
Professor Emeritus, University of Tennessee Health Science Center
IPT Therapist
Professional Biography
Position: College of Pharmacy
Academic Affiliation: University of Tennessee Health Science Center
Professional Degree: PharmD, MS Psychology, MS Nursing
Primary Language: English
Secondary Language: None
Level A Training Completed: 06/29/2021
CURRICULUM VITAE
CANDACE SUSANNE BROWN, PharmD, MSN
CONTACT INFORMATION:
Email: csbrown@uthsc.edu
Telephone: 901-412-4341
Address: 9685 Highway 70, Arlington, TN 38002
EDUCATION:
Undergraduate:
Central Washington University, Ellensburg, WA, 09/68 – 6/71, B.A Psychology, 06/71
University of Washington, Seattle, WA, 09/73 – 06/77, B.S. Pharmacy, 06/77
University of Alaska, Anchorage, AK, 09/79 – 12/82, B.S. Nursing, 12/81
Graduate/Professional School:
Central Washington University, Ellensburg, WA, 09/71 - 09/74, M.S. Psychology, 09/74
University of Washington, Seattle, WA, 06/83 - 06/85, Doctor of Pharmacy, 06/85
University of Tennessee Health Science Center, Memphis, TN, 06/94 - 06/96, M.S. Nursing
Residency:
General Adult (ASHP accredited), Harborview Medical Center, Seattle, WA 06/83 - 06/85
Fellowship:
Psychopharmacotherapy, Psychiatry Dept., U Tex. Med Br., Galveston, TX 07/85 - 07/87
HONORS/AWARDS:
Fellow, International Society for the Study of Vulvovaginal Disease (ISSVD), 2013
Sigma Theta Tau International Honor Society of Nursing, Theta Omicron Chapter, 1987
BOARD CERTIFICATION:
ANCC, Family Nurse Practitioner (FNP-BC), 9/1/96, active
ANCC, Adult Psychiatric-Mental Health Clinical Nurse Specialist (PMHCNS-BC), 9/1/97, active
AASECT, Certified Sex Therapist, 4/1/05 – 12/31/12, inactive
Board of Pharmaceutical Specialties, Psychiatric Pharmacy (BCPP), 7/1/19 – 6/30/26, active
LICENSURE:
Pharmacy:
• Tennessee, #C007154, 06/30/1988, Active
Nursing:
• Tennessee, Advanced Practice Registered Nurse, #APN006384, 01/31/96, Active
• Tennessee, Registered Nurse, #081938, 01/31/90, Active
APPOINTMENTS - UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER (past 5 yrs.)
Professor Emeritus, Department of Pharmacy & Translational Sciences, 2018-present
Professor (Tenured), Department of Pharmacy & Translational Sciences (Primary), 1998-2018
Professor, Department of Psychiatry (Secondary), 1999-2015.
Professor, Department of Obstetrics and Gynecology (Secondary), 1999-2016.
PRACTICE/PROFESSIONAL EXPERIENCE:
Psychiatric Family Nurse Practitioner:
Clinical Research Center, Memphis, TN – NIH-funded Gabapentin Clinical Trial (2011 – 2016)
• Completed medical and psychiatric history
• Performed physical and pelvic exams
• Ordered and evaluated labs
• Diagnosed and enrolled eligible participants with provoked vulvodynia
• Diagnosed & referred ineligible participants with other vulvar conditions
• Diagnosed & referred ineligible participants with psychiatric disorders
• Prescribed therapy during the study (antibiotics, antifungals, estrogen therapy)
Women’s Health Specialists, Germantown, TN (2005 – 2011)
• Completed medical and psychiatric history
• Ordered and evaluated labs
• Diagnosed mood, anxiety, sexual and pain disorders
• Provided individual, sexual and couple counseling
• Prescribed therapy (antidepressants, anxiolytics)
Southeast Urology Network, Memphis, TN (2005 – 2007)
• Completed medical and psychiatric history
• Ordered and evaluated labs
• Diagnosed with erectile dysfunction, premature ejaculation, and desire disorders
• Provided individual and sexual counseling
• Prescribed therapy (PDE-5 inhibitors, testosterone, antidepressants)
Clinical Pharmacist:
UT Medical Group, Inc., Obstetrics & Gynecology, Germantown, TN (1992 – 2005)
• Counseled patients on medications
• Provided medication consultation to physicians
Midtown Mental Health Center, Memphis, TN (1987 – 1992)
• Counseled patients on medications
• Provided medication consultation to physicians
TEACHING EXPERIENCE: (College of Pharmacy)
Direct Instruction
Course Director
• Psychiatry and Substance Abuse (PHCY 3101), 3.5 hrs., past
• Patient Assessment, 2.0 hrs., past
Lecturer
• Interprofessional Education & Clinical Simulation (IPECS 2), (PHCY 1205), 1 hr., current
• Interprofessional Education & Clinical Simulation (IPECS 3) (PHCY 217), 1.0 hr., current
• Interprofessional Education & Clinical Simulation (IPECS 4), (PHC 227), 1.0 hr., current
• Foundations of Pharmacy (PHCY 1104), 2.5 hr., current
• Women’s Health Elective (PHCY 5002), 3.0 hrs., past
• Therapeutics IV (PHCY 222), DSM-IV Classifications, 1.0 hr., past
• Therapeutics IV, Mental Status Exam (PHCY 222), 1.0 hr., past
• Therapeutics IV (PHCY 222), Major Depression, 1.0 hr., past
• Therapeutics IV, Bipolar Disorder (PHCY 222), 1.0 hr., past
• Therapeutics IV, Sexual Disorders (PHCY 222), 1.0 hr., past
• Literature Evaluation & Study Design (PHCY 2204), 1.0 hr. past
Experiential Education
• Clinical Research II (PHCY 466), Advanced Pharmacy Practice (APPE), 4.0 hr., past
• Obstetrics-Gynecology (PHCY 435), Advanced Pharmacy Practice (APPE), 4.0 hr., past
• Mental Health I (PHY 470), Advanced Pharmacy Practice (APPE), 4.0 hr., past
• Mental Health II (PHY 471), Advanced Pharmacy Practice (APPE), 4.0 hr., past
Student Mentorship
• Residents: 4 Psychiatry, 2 Women’s Health
• Fellows: 1 Psychiatry, 1 Women’s Health, 2 Clinical Research
VISITING PROFESSORSHIP:
Department of Ob/Gyn, Rutgers-Robert Wood Johnson Medical School, NJ, current
Department of Psychiatry, Rutgers-Robert Wood Johnson Medical School, past
GRANT ADVISORY COMMITTEES AND STUDY SECTIONS:
NICHD, Chair, Gynecologic Pain Syndromes Working Group, Gyn Health & Dis Branch, 2016
NICHD, Reproductive Sciences Small Business Special Emphasis Panel, 2014
NICHD, Urologic and Genitourinary Physiology and Pathology Special Emphasis Panel, 2013
NICHD, Reproductive Science Development Program Special Emphasis Panel, 2011 – 2013
NICHD, Endocrinology, Metabolism, Nutrition and Reproductive Sciences Study Section, 2012
NINR, Social Sciences, Nursing, Epidemiology and Methods, 2001 – 2003
RESEARCH AND OTHER EXTERNAL SUPPORT (last 5 years):
1. National Institute of Health (R01 HD065740), National Institute of Child Health & Human Development (NICHD). “A controlled trial of gabapentin in vulvodynia: Biological correlates of response. (P 07-182), Consortium: C Brown (UTHSC), G Bachmann (Rutgers-Robert Wood Johnson Medical School), D Foster (University of Rochester School of Medicine & Dentistry), $2,550,281, 3/1/11 – 2/28/15, 25% Effort, Core Site Principal Investigator.
2. National Vulvodynia Association (NVA). “Development of a Protocol Template for Clinical Research in Vulvodynia,” $15,750, 10/1/15 – 9/31/16, 4.2% Principal Investigator.
3. National Vulvodynia Association (NVA). “Development of a Patient-Reported Outcome Measure for Quality of Pain in Women with Vulvodynia,” $7,150, 10/01/16 – 9/30/19. 0% Effort, Principal Investigator.
BOOKS AND BOOK CHAPTERS (last 5 years):
1. Bachmann G, Brown C, Foster D. History and Meaning of Pain: Gynaecologic Implications for Women with Vulvodynia. In: Studd J, Tan SL, Chervenak FA, eds. Current Progress in Obstetrics and Gynecology, Philadelphia, PA: Elsevier; 2015.
2. Pukall CF, Goldstein AT, Bergeron S, Foster D, Stein A, Kellogg-Spadt S, Brown C, Bachmann G, Cahill C, Damsted Petersen C. Women’s Sexual Pain Disorders. Fourth International Consultation on Sexual Medicine (ICSM) online publication. In: Porst H, Buvat J. Eds. Standard Practice in Sexual Medicine. Malden, MA: Blackwell Publishing; 2016.26.
3. Bachour C, Brown CS. Sexual Health Problems and Dysfunction. In: Alexander I, Johnson-Mallard, Kostas-Polston, Fogel, eds. Women's Healthcare in Advanced Practice Nursing. 2nd ed. New York, NY: Springer Publishing Company, 2017.
4. Bachour C, Brown CS. Women’s Health. In: Lee M, ed. Basic Skills in Interpreting Laboratory Data, 6th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2017.
5. Brown C, Bachour C, Bachmann G. Principles of Medical Treatment of Vulvar Conditions. In: Bornstein J, ed. Interdisciplinary Approach to Vulvar Disease. New York, NY: Springer, 2018.
6. Brown C. Treatment of neuroproliferative-associated provoked vestibulodynia. In: Pukall C, ed. Female Sexual Pain Disorders: Evaluation and Management. 2nd ed. Indianapolis, IN Wiley Publishing, 2019.
PEER-REVIEWED JOURNAL ARTICLES (last 5 years):
1. Brown C, Foster D, Bachour C, Rawlinson L, Wan J, Bachmann G. Presenting symptoms among black and white women with vestibulodynia. J Women’s Health. 2015; 10:831-6.
2. Phillips N, Brown C, Foster D, F Bachour C, Rawlinson L, Wan J, Bachmann G. Presenting symptoms in premenopausal and postmenopausal women with vulvodynia: A case series. Menopause. 2015, Dec; 22(12):1296-300.
3. Brown C, Bachmann G, Wan J, Foster D. Pain ratings in women with provoked vestibulodynia: Evaluating influence of race. J Women’s Health. 2016; 25:57-62.
4. Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: Assessment and treatment. J Sex Med. 2016;13(4):572-90.
5. Phillips N, Brown C, Bachmann G, Wan J, Wood R, Ulrich D, Bachour C, Foster D. Relationship between tender point tenderness and vaginal algometer pain intensity ratings in women with provoked vulvodynia and implications for treatment. Am J Obstet Gynecol 2016.
6. Bachour C, Bachmann GA, Foster D, Wan J, Rawlinson L, Brown C. Recruitment in a Clinical Trial of Provoked Vulvodynia: Predictors of Enrollment. Clin Trials 2017; 14:103-108.
7. Pukall C, Bergeron S, Brown C, Bachmann G, Wesselmann U. Recommendations of self-report outcome measures in vulvodynia clinical trials. Clin J Pain 2017; 33:756-65.
8. Brown CS, Bachmann G, Wan J, Foster DC. Gabapentin for the treatment of vulvodynia: A randomized controlled trial. Obstet Gynecol 2018; 131:1-9.
9. Bachmann GA, Brown CS, Phillips NA, Rawlinson LA, Yu X, Wood, R, Foster. Effect of gabapentin on sexual function in vulvodynia: A randomized, placebo-controlled trial. Am J Obstet Gynecol 2019; 220:89.e1-89.e8.
RECENT PRESENTATIONS (last 5 years):
1. The University of British Columbia. “Development of a Patient-Rated Outcome in Women with Vulvodynia,” Vancouver, British Columbia, September 2018.
Contact Info
Email: csbrown@uthsc.edu
Phone: 9014124341
Fax: 901-867-0749
Website: http://
Address:
9685 Highway 70
Arlington, Tennessee, 38002
United States